Should we add pravastatin to aspirin for preeclampsia prevention in high-risk women?
CC Marrs, MM Costantine�- Clinical obstetrics and gynecology, 2017 - journals.lww.com
Preeclampsia is a multisystem disorder that affects 3% to 5% of pregnant women and
remains a significant source of short-term and long-term maternal and neonatal mortality
and morbidity. Many professional societies recommend the use of low-dose aspirin to
prevent preeclampsia in high-risk women. Owing to the similarities in pathophysiology
between preeclampsia and atherosclerotic cardiovascular disease, and the encouraging
data from preclinical and pilot clinical studies, pravastatin has been proposed for preventing�…
remains a significant source of short-term and long-term maternal and neonatal mortality
and morbidity. Many professional societies recommend the use of low-dose aspirin to
prevent preeclampsia in high-risk women. Owing to the similarities in pathophysiology
between preeclampsia and atherosclerotic cardiovascular disease, and the encouraging
data from preclinical and pilot clinical studies, pravastatin has been proposed for preventing�…